Hubert Department of Global Health, Rollins School of Public Health, Atlanta, Georgia, USA
Emory Vaccine Center, Atlanta, Georgia, USA.
BMJ Open. 2022 Apr 29;12(4):e058321. doi: 10.1136/bmjopen-2021-058321.
Increases in global childhood vaccine delivery have led to decreases in morbidity from vaccine-preventable diseases. However, these improvements in vaccination have been heterogeneous, with some countries demonstrating greater levels of change and sustainability. Understanding what these high-performing countries have done differently and how their decision-making processes will support targeted improvements in childhood vaccine delivery.
We studied three countries-Nepal, Senegal, Zambia-with exemplary improvements in coverage between 2000 and 2018 as part of the Exemplars in Global Health Programme. We apply established implementation science frameworks to understand the 'how' and 'why' underlying improvements in vaccine delivery and coverage. Through mixed-methods research, we will identify drivers of catalytic change in vaccine coverage and the decision-making process supporting these interventions and activities. Methods include quantitative analysis of available datasets and in-depth interviews and focus groups with key stakeholders in the global, national and subnational government and non-governmental organisation space, as well as community members and local health delivery system personnel.
Working as a multinational and multidisciplinary team, and under oversight from all partner and national-level (where applicable) institutional review boards, we collect data from participants who provided informed consent. Findings are disseminated through a variety of forms, including peer-reviewed manuscripts related to country-specific case studies and vaccine system domain-specific analyses, presentations to key stakeholders in the global vaccine delivery space and narrative dissemination on the Exemplars.Health website.
全球儿童疫苗接种率的提高导致了可通过疫苗预防的疾病发病率的下降。然而,这些疫苗接种方面的改进是不均衡的,一些国家的变化和可持续性水平更高。了解这些表现出色的国家有何不同,以及他们的决策过程如何支持有针对性地改善儿童疫苗接种。
我们研究了三个国家——尼泊尔、塞内加尔和赞比亚,它们在 2000 年至 2018 年期间在覆盖率方面表现出色,是全球健康计划中的典范。我们应用既定的实施科学框架来了解疫苗接种和覆盖率提高背后的“如何”和“为什么”。通过混合方法研究,我们将确定推动疫苗覆盖率催化变化的因素,以及支持这些干预措施和活动的决策过程。方法包括对现有数据集的定量分析,以及对全球、国家和国家以下各级政府和非政府组织领域的主要利益攸关方以及社区成员和当地卫生服务系统人员进行深入访谈和焦点小组。
作为一个多国家和多学科的团队,在所有合作伙伴和国家层面(如适用)机构审查委员会的监督下,我们从提供知情同意的参与者那里收集数据。研究结果通过多种形式传播,包括与特定国家案例研究和疫苗系统特定领域分析相关的同行评议手稿、向全球疫苗接种领域的主要利益攸关方展示以及在典范健康网站上进行叙述传播。